Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.

× No keyword cloud information.

44 in total

1. The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease.

Authors: Nicola C Edwards; Richard P Steeds; Colin D Chue; Paul M Stewart; Charles J Ferro; Jonathan N Townend
Journal: Br J Clin Pharmacol Date: 2012-03 Impact factor: 4.335

Review 2. Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors: John M Hamlyn; Paolo Manunta
Journal: Adv Chronic Kidney Dis Date: 2015-05 Impact factor: 3.620

3. Endothelin receptor antagonists in proteinuric renal disease: every rose has its thorn.

Authors: Eberhard Ritz; René Wenzel
Journal: J Am Soc Nephrol Date: 2010-02-04 Impact factor: 10.121

Review 4. The RAAS in the pathogenesis and treatment of diabetic nephropathy.

Authors: Piero Ruggenenti; Paolo Cravedi; Giuseppe Remuzzi
Journal: Nat Rev Nephrol Date: 2010-05-04 Impact factor: 28.314

Review 5. Novel drugs and intervention strategies for the treatment of chronic kidney disease.

Authors: Hiddo Jan Lambers Heerspink; Dick de Zeeuw
Journal: Br J Clin Pharmacol Date: 2013-10 Impact factor: 4.335

Review 6. The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.

Authors: Atsuhisa Sato
Journal: Hypertens Res Date: 2015-03-12 Impact factor: 3.872

7. Aldosterone and TGF-β₁ synergistically increase PAI-1 expression in hepatic stellate cells of rats.

Authors: Sheng-Lan Wang; Hui-Min Wu; Cheng-Zhi He; Li Yang; Heng-Jun Gao; Chang-Qing Yang
Journal: Int J Clin Exp Pathol Date: 2015-09-01

Review 8. Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors: Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal: Nat Rev Nephrol Date: 2012-10-16 Impact factor: 28.314

9. Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.

Authors: Akira Nishiyama; Hiroyuki Kobori; Yoshio Konishi; Takashi Morikawa; Isseki Maeda; Michiaki Okumura; Masatsugu Kishida; Masahiro Hamada; Yukiko Nagai; Toshitaka Nakagawa; Naro Ohashi; Daisuke Nakano; Hirofumi Hitomi; Masahito Imanishi
Journal: J Pharmacol Exp Ther Date: 2009-11-25 Impact factor: 4.030

10. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.

Authors: Liffert Vogt; Femke Waanders; Frans Boomsma; Dick de Zeeuw; Gerjan Navis
Journal: J Am Soc Nephrol Date: 2008-02-13 Impact factor: 10.121